Literature DB >> 33457405

Differential Expression of Urinary Exosomal Small RNAs in Idiopathic Membranous Nephropathy.

Jinshi Zhang1,2,3,4, Yifan Zhu2,3,4, Ruyi Cai1,2,3,4, Juan Jin2,3,4, Qiang He2,3,4.   

Abstract

BACKGROUND: Idiopathic membranous nephropathy (IMN) is a major cause of adult nephrotic syndromes, and reliable noninvasive biomarkers for diagnosis and monitoring are urgently needed. In this study, we performed small RNA (sRNA) sequencing to explore sRNA profiles of urinary exosomes derived from IMN patients and healthy controls (CON) to provide clues for identifying novel noninvasive sRNA biomarkers for IMN.
METHODS: Urine samples were collected from five healthy controls and six patients with IMN. High-throughput sequencing was used to screen sRNA expression profiles of urinary exosomes from patients with IMN in two independent cohorts.
RESULTS: Urinary exosomes were successfully isolated and used to obtain exosomal sRNAs. We screened 131 differentially expressed miRNAs, including 28 specifically expressed miRNAs, then explored the top 10 specifically expressed miRNAs in all IMN individuals. The specifically expressed miRNAs and differentially expressed miRNAs provide potential biomarkers for IMN. Additionally, we discovered numerous sRNAs derived from genomic repetitive sequences, which could represent an exciting new area of research.
CONCLUSION: Herein, we revealed significant differences in expression profiles of urinary exosomal miRNAs and repetitive region-derived sRNAs between patients with IMN and healthy controls. The findings could facilitate the development of potential molecular targets for membranous nephropathy.
Copyright © 2020 Jinshi Zhang et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33457405      PMCID: PMC7785370          DOI: 10.1155/2020/3170927

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  44 in total

1.  Using RepeatMasker to identify repetitive elements in genomic sequences.

Authors:  Maja Tarailo-Graovac; Nansheng Chen
Journal:  Curr Protoc Bioinformatics       Date:  2009-03

2.  Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.

Authors:  Xiao Lei; Bo-da Zhang; Ji-Gang Ren; Fang-Li Luo
Journal:  Life Sci       Date:  2018-05-22       Impact factor: 5.037

Review 3.  Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis.

Authors:  Shou-Liang Hu; Dan Wang; Wen-Jun Gou; Qing-Feng Lei; Te-An Ma; Jun-Zhang Cheng
Journal:  J Nephrol       Date:  2014-02-06       Impact factor: 3.902

4.  Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy.

Authors:  Juan Jin; Huifang Zhan; Bo Lin; Yiwen Li; Wei Zhang; Qiang He
Journal:  Int Urol Nephrol       Date:  2017-03-11       Impact factor: 2.370

5.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Authors:  Ben Langmead; Cole Trapnell; Mihai Pop; Steven L Salzberg
Journal:  Genome Biol       Date:  2009-03-04       Impact factor: 13.583

Review 6.  Glomerular diseases: membranous nephropathy--a modern view.

Authors:  Claudio Ponticelli; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

7.  Genome-wide mapping of infection-induced SINE RNAs reveals a role in selective mRNA export.

Authors:  John Karijolich; Yang Zhao; Ravi Alla; Britt Glaunsinger
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

8.  miR-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients.

Authors:  Li Chen; Congzhi Li; Zaiquan Peng; Jinxiang Zhao; Guozhong Gong; Deming Tan
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

9.  Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension.

Authors:  Javier Perez-Hernandez; Dolores Olivares; Maria J Forner; Ana Ortega; Elena Solaz; Fernando Martinez; Felipe J Chaves; Josep Redon; Raquel Cortes
Journal:  J Transl Med       Date:  2018-08-14       Impact factor: 5.531

10.  MiR-92b-3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy.

Authors:  Li-Ping Wang; Jia-Nan Geng; Bo Sun; Cheng-Bo Sun; Yan Shi; Xiao-Yan Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-06       Impact factor: 2.629

View more
  6 in total

1.  Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy.

Authors:  In O Sun; Yun-Ui Bae; Kyung-Oh Doh; Soon Hyo Kwon; Haekyung Lee; Hyoungnae Kim; Jin Seok Jeon; Hyunjin Noh; Jong-Soo Choi
Journal:  J Transl Med       Date:  2022-05-14       Impact factor: 8.440

Review 2.  Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis.

Authors:  Marco Quaglia; Guido Merlotti; Laura Fornara; Andrea Colombatto; Vincenzo Cantaluppi
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  Integrative analysis of miRNA-mRNA network in idiopathic membranous nephropathy by bioinformatics analysis.

Authors:  Wenfang He; Jinshi Zhang; Shizhu Yuan; Mingzhu Liang; Weidong Chen; Juan Jin
Journal:  PeerJ       Date:  2021-09-29       Impact factor: 2.984

Review 4.  The Clinical Significance of Transfer RNAs Present in Extracellular Vesicles.

Authors:  Daniel S K Liu; Qi Zhi Clayton Yang; Mohammad Asim; Jonathan Krell; Adam E Frampton
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 5.  Novel Biomarkers in Membranous Nephropathy.

Authors:  Qiuying Liu; Jianhua Liu; Baoxu Lin; Yue Zhang; Meichen Ma; Mei Yang; Xiaosong Qin
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

6.  MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy.

Authors:  Xiaoshan Zhou; Haoran Dai; Hanxue Jiang; Hongliang Rui; Wenbin Liu; Zhaocheng Dong; Na Zhang; Qihan Zhao; Zhendong Feng; Yuehong Hu; Fanyu Hou; Yang Zheng; Baoli Liu
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.